US2007231891A1PendingUtilityA1

Ribonucleases and methods of making them recombinantly

Assignee: ALFACELL CORPPriority: Jul 17, 2003Filed: Jun 7, 2007Published: Oct 4, 2007
Est. expiryJul 17, 2023(expired)· nominal 20-yr term from priority
C12N 9/22A61P 35/00C07K 2319/01C12N 15/09C12N 15/52
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for recombinantly producing new RNases, as well as previously-known RNases, are disclosed. The new RNases are actable against human carcinoma cells.

Claims

exact text as granted — not AI-modified
1 . (canceled)  
     
     
         2 . (canceled)  
     
     
         3 . (canceled)  
     
     
         4 . (canceled)  
     
     
         5 . (canceled)  
     
     
         6 . (canceled)  
     
     
         7 . (canceled)  
     
     
         8 . (canceled)  
     
     
         9 . (canceled)  
     
     
         10 . A protein having the amino acid sequence of SEQ ID NO:60 produced recombinantly.  
     
     
         11 . (canceled)  
     
     
         12 . (canceled)  
     
     
         13 . (canceled)  
     
     
         14 . (canceled)  
     
     
         15 . (canceled)  
     
     
         16 . (canceled)  
     
     
         17 . (canceled)  
     
     
         18 . (canceled)  
     
     
         19 . (canceled)  
     
     
         20 . A protein having the amino acid sequence of SEQ ID NO:60.  
     
     
         21 . A conservatively modified variant of the protein of  claim 20 .  
     
     
         22 . A gene that when expressed in a host encodes the protein of  claim 20 .  
     
     
         23 . A gene that when expressed in a host encodes the protein of  claim 21 .  
     
     
         24 . (canceled)  
     
     
         25 . (canceled)  
     
     
         26 . (canceled)  
     
     
         27 . (canceled)  
     
     
         28 . (canceled)  
     
     
         29 . (canceled)  
     
     
         30 . (canceled)  
     
     
         31 . (canceled)  
     
     
         32 . (canceled)  
     
     
         33 . (canceled)  
     
     
         34 . (canceled)  
     
     
         35 . (canceled)  
     
     
         36 . (canceled)  
     
     
         37 . (canceled)  
     
     
         38 . (canceled)  
     
     
         39 . (canceled)  
     
     
         40 . (canceled)  
     
     
         41 . (canceled)  
     
     
         42 . A protein having the amino acid sequence of SEQ ID NO:17 preceded at its N-terminal end by a leader sequence that has at least the first and at most all of the residues of SEQ ID NO:64 in order.  
     
     
         43 . A protein having the amino acid sequence of SEQ ID NO:17 preceded at its N-terminal end by a leader sequence that has at least the first and at most all of the residues of SEQ ID NO:66 in order.  
     
     
         44 . (canceled)  
     
     
         45 . (canceled)  
     
     
         46 . (canceled)  
     
     
         47 . (canceled)  
     
     
         48 . (canceled)  
     
     
         49 . (canceled)  
     
     
         50 . (canceled)  
     
     
         51 . (canceled)  
     
     
         52 . (canceled)  
     
     
         53 . (canceled)  
     
     
         54 . (canceled)  
     
     
         55 . (canceled)  
     
     
         56 . (canceled)  
     
     
         57 . A vector containing DNA of SEQ ID NO:18 encoding the Ribonuclease of SEQ ID NO:17.

Join the waitlist — get patent alerts

Track US2007231891A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.